Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.
Open Access
- 1 April 1996
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 133 (1) , 185-197
- https://doi.org/10.1083/jcb.133.1.185
Abstract
Laminin-2 is a component of skeletal and cardiac basal lamina expressed in normal mouse and human. Laminin alpha2 chain (LAMA2), however, is absent from muscles of some congenital muscular dystrophy patients and the dystrophia muscularis (dy/dy) mouse model. LAMA2 restoration was investigated following cell transplantation in vivo in dy/dy mouse. Allogeneic primary muscle cell cultures expressing the beta-galactosidase transgene under control of a muscular promoter, or histocompatible primary muscle cell cultures, were transplanted into dy/dy mouse muscles. FK506 immunosuppression was used in noncompatible models. All transplanted animals expressed LAMA2 in these immunologically-controlled models, and the degrees of LAMA2 restoration were shown to depend on the age of the animal at transplantation, on muscle pretreatment, and on duration time after transplantation in some cases. LAMA2 did not always colocalize with new or hybrid muscle fibers formed by the fusion of donor myoblasts. LAMA2 deposition around muscle fibers was often segmental and seemed to radiate from the center to the periphery of the injection site. Allogeneic conditionally immortalized pure myogenic cells expressing the beta-galactosidase transgene were characterized in vitro and in vivo. When injected into FK506-immunosuppressed dy/dy mice, these cells formed new or hybrid muscle fibers but essentially did not express LAMA2 in vivo. These data show that partial LAMA2 restoration is achieved in LAMA2-deficient dy/dy mouse by primary muscle cell culture transplantation. However, not all myoblasts, or myoblasts alone, or the muscle fibers they form are capable of LAMA2 secretion and deposition in vivo.Keywords
This publication has 52 references indexed in Scilit:
- FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1995
- Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy 22–24 April 1994, The NetherlandsNeuromuscular Disorders, 1995
- Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers.The Journal of cell biology, 1994
- Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantationMuscle & Nerve, 1994
- Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissuesThe Journal of cell biology, 1994
- Merosin promotes cell attachment and neurite outgrowth and ls a component of the neurite-promoting factor of RN22 schwannoma cellsExperimental Cell Research, 1992
- Formation of new muscle fibres and tumours after injection of cultured myogenic cellsJournal of Neurocytology, 1991
- X‐Irradiation improves mdx mouse muscle as a model of myofiber loss in DMDMuscle & Nerve, 1991
- Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblastsNature, 1989
- The contribution of exogenous cells to regenerating skeletal muscle : An isoenzyme study of muscle allografts in miceThe Journal of Pathology, 1980